세계의 BNP 및 NT-proBNP 시장 규모 : 용도별, 검사 장소별, 지역별 예측(2022-2032년)

Global BNP And NTproBNP Market is valued at approximately USD 1253.2 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2024-2032. BNP (B-type Natriuretic Peptide) and NT-proBNP (N-terminal prohormone of BNP) are biomarkers used to diagnose heart failure. BNP is a hormone produced by the heart's ventricles in response to increased pressure and volume overload. NT-proBNP (N-terminal pro b-type Natriuretic Peptide) is a precursor to BNP (B-type Natriuretic Peptide), both of which are released by the heart in response to ventricular volume expansion and pressure overload. NT-proBNP is cleaved from the same precursor molecule as BNP and is used as a biomarker for diagnosing and managing heart failure due to its stability and longer half-life in circulation. Both BNP and NT-proBNP levels are used in clinical settings to assess the severity of heart failure, guide treatment, and predict patient outcomes. Their measurement is crucial for managing heart failure patients effectively. The Global BNP and NT-proBNP Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and increasing awareness about early diagnosis and management of heart failure. Advances in diagnostic technologies and a growing elderly population are drifting demand. Additionally, increasing healthcare expenditures and expanding healthcare infrastructure in emerging markets are further propelling market expansion.

The BNP And NTproBNP market are propelled by the rising prevalence of cardiovascular diseases and the increasing demand for early diagnosis and effective heart failure management. Advances in diagnostic technology enhance the accuracy and efficiency of these tests, leading to greater adoption in clinical settings. The aging global population, which is more susceptible to heart conditions, further drives market demand. Additionally, rising healthcare expenditures and the expansion of healthcare infrastructure, particularly in emerging markets, contribute to market growth. Increased awareness among patients and healthcare providers about the importance of early detection and intervention also supports the market. Continuous research and development efforts result in innovative products and improved diagnostic capabilities, further boosting the market. However, lack of awareness and limited availability of advanced healthcare facilities in developing countries hinder market growth. Reimbursement issues and stringent regulatory requirements also pose challenges to market expansion.

The key regions considered for the Global BNP And NTproBNP Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominates the market in terms of revenue. The BNP And NTproBNP market in North America is characterized by its advanced healthcare infrastructure, which facilitates the widespread adoption of sophisticated diagnostic technologies. The region has a high prevalence of cardiovascular diseases, necessitating early and accurate diagnosis for effective management. Substantial healthcare spending in North America ensures access to advanced diagnostic tests and treatments. Additionally, strong research and development activities contribute to continuous innovation and improvement in diagnostic tools. Widespread awareness among healthcare providers and patients about the importance of early detection and intervention further drives market growth. Supportive government policies and reimbursement frameworks also play a crucial role in the market's dominance in this region. The Asia-Pacific region is the fastest-growing market for BNP And NTproBNP globally.

Major market player included in this report are:

• Siemens AG
• Biomerieux SA
• F Hoffman La Roche Ltd.
• Danaher Corporation
• Quidel Corporation
• PerkinElmer Inc.
• Gentian Diagnostics ASA
• Scripps Laboratories
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.

The detailed segments and sub-segment of the market are explained below:

By Application

• Myocardial Infarction
• Congestive Heart Failure
• Acute Coronary Syndrome (ACS)
• Others

By Location of Testing

• Point of Care Testing
• Laboratory Testing

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global BNP And NTproBNP Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global BNP And NTproBNP Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Application
  • 2.3.2. By Location of Testing
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global BNP And NTproBNP Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global BNP And NTproBNP Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global BNP And NTproBNP Market Size & Forecasts by Application 2022-2032

• 5.1. Myocardial Infarction
• 5.2. Congestive Heart Failure
• 5.3. Acute Coronary Syndrome (ACS)
• 5.4. Others

Chapter 6. Global BNP And NTproBNP Market Size & Forecasts by Location of Testing 2022-2032

• 6.1. Point of Care Testing
• 6.2. Laboratory Testing

Chapter 7. Global BNP And NTproBNP Market Size & Forecasts by Region 2022-2032

• 7.1. North America BNP And NTproBNP Market
  • 7.1.1. U.S. BNP And NTproBNP Market
    • 7.1.1.1. Application breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Location of Testing breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada BNP And NTproBNP Market
• 7.2. Europe BNP And NTproBNP Market
  • 7.2.1. U.K. BNP And NTproBNP Market
  • 7.2.2. Germany BNP And NTproBNP Market
  • 7.2.3. France BNP And NTproBNP Market
  • 7.2.4. Spain BNP And NTproBNP Market
  • 7.2.5. Italy BNP And NTproBNP Market
  • 7.2.6. Rest of Europe BNP And NTproBNP Market
• 7.3. Asia-Pacific BNP And NTproBNP Market
  • 7.3.1. China BNP And NTproBNP Market
  • 7.3.2. India BNP And NTproBNP Market
  • 7.3.3. Japan BNP And NTproBNP Market
  • 7.3.4. Australia BNP And NTproBNP Market
  • 7.3.5. South Korea BNP And NTproBNP Market
  • 7.3.6. Rest of Asia Pacific BNP And NTproBNP Market
• 7.4. Latin America BNP And NTproBNP Market
  • 7.4.1. Brazil BNP And NTproBNP Market
  • 7.4.2. Mexico BNP And NTproBNP Market
  • 7.4.3. Rest of Latin America BNP And NTproBNP Market
• 7.5. Middle East & Africa BNP And NTproBNP Market
  • 7.5.1. Saudi Arabia BNP And NTproBNP Market
  • 7.5.2. South Africa BNP And NTproBNP Market
  • 7.5.3. Rest of Middle East & Africa BNP And NTproBNP Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Siemens AG
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Biomerieux SA
  • 8.3.3. F Hoffman La Roche Ltd.
  • 8.3.4. Danaher Corporation
  • 8.3.5. Quidel Corporation
  • 8.3.6. PerkinElmer Inc.
  • 8.3.7. Gentian Diagnostics ASA
  • 8.3.8. Scripps Laboratories
  • 8.3.9. Abbott Laboratories
  • 8.3.10. Bio-Rad Laboratories, Inc.

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes